key: cord-1024389-kisqurzi
authors: Wang, Julia Y.; Zhang, Wei; Roehrl, Michael W.; Roehrl, Victor B.; Roehrl, Michael H.
title: An Autoantigen Profile from Jurkat T-Lymphoblasts Provides a Molecular Guide for Investigating Autoimmune Sequelae of COVID-19
date: 2021-07-07
journal: bioRxiv
DOI: 10.1101/2021.07.05.451199
sha: 683321dcb1a90cbd5cfde69a0c4007780eee4605
doc_id: 1024389
cord_uid: kisqurzi

In order to understand autoimmune phenomena contributing to the pathophysiology of COVID-19 and post-COVID syndrome, we have been profiling autoantigens (autoAgs) from various cell types. Although cells share numerous autoAgs, each cell type gives rise to unique COVID-altered autoAg candidates, which may explain the wide range of symptoms experienced by patients with autoimmune sequelae of SARS-CoV-2 infection. Based on the unifying property of affinity between autoantigens (autoAgs) and the glycosaminoglycan dermatan sulfate (DS), this paper reports 140 candidate autoAgs identified from proteome extracts of human Jurkat T-cells, of which at least 105 (75%) are known targets of autoantibodies. Comparison with currently available multi-omic COVID-19 data shows that 125 (89%) of DS-affinity proteins are altered at protein and/or RNA levels in SARS-CoV-2-infected cells or patients, with at least 94 being known autoAgs in a wide spectrum of autoimmune diseases and cancer. Protein alterations by ubiquitination and phosphorylation in the viral infection are major contributors of autoAgs. The autoAg protein network is significantly associated with cellular response to stress, apoptosis, RNA metabolism, mRNA processing and translation, protein folding and processing, chromosome organization, cell cycle, and muscle contraction. The autoAgs include clusters of histones, CCT/TriC chaperonin, DNA replication licensing factors, proteasome and ribosome proteins, heat shock proteins, serine/arginine-rich splicing factors, 14-3-3 proteins, and cytoskeletal proteins. AutoAgs such as LCP1 and NACA that are altered in the T cells of COVID patients may provide insight into T-cell responses in the viral infection and merit further study. The autoantigen-ome from this study contributes to a comprehensive molecular map for investigating acute, subacute, and chronic autoimmune disorders caused by SARS-CoV-2.

The COVID-19 pandemic has been devastating. After initial recovery from acute SARS-CoV-2 infection, many people continue to suffer from lingering health problems (so called "long COVID" or post-COVID syndrome), such as fatigue, shortness of breath, joint pain, chest pain, muscle pain, loss of smell or taste, and other neurological problems. Although the underlying causes are far from clear, autoimmune effects are likely important contributors to chronic post-COVID disorders. To understand how SARS-CoV-2 infection may induce autoimmune responses, we are establishing a comprehensive COVID autoantigen atlas, i.e., all possible endogenous autoantigens (autoAgs) that may be rendered immunogenic by the viral infection. Because different tissues or cells may give rise to distinct pools of autoAgs, we have been profiling autoAgs from multiple human tissues and cell types, including human lung fibroblast HFL1 cells, human lung epithelial-like A549 cells, and B-lymphoblast HS-Sultan cells [1] [2] [3] [4] . In this study, we report an autoantigen-ome identified from human Jurkat T-lymphoblast cells.

Our autoAg discovery is based a unifying mechanism of autoantigenicity that we have uncovered [5] [6] [7] [8] .

AutoAgs are the targets of autoantibodies (autoAbs) and T-cell autoimmune responses. Typically, selfmolecules are naturally tolerated by the immune system and do not provoke autoimmune responses.

However, certain self-molecules transform into autoAgs and become targets of autoimmune attacks. Thus far, hundreds of autoAgs with seemingly no obvious structural or functional commonality have been identified across various autoimmune diseases and cancers. Our studies have demonstrated that autoAgs do, in fact, share common properties. AutoAgs are commonly released by apoptotic cells, and we found that the glycosaminoglycan dermatan sulfate (DS) has peculiar affinity to apoptotic cells and their autoAgs [5, 7, 8] . DS and autoAgs can form affinity complexes and cooperatively stimulate autoreactive B1 cells and autoantibody production [5, 7, 8] . Based on autoAg-DS affinity, we have identified several hundred autoAgs from various cells and tissues [1] [2] [3] [9] [10] [11] .

A variety of autoantibodies have been identified in COVID-19 patients [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] . Children infected with found in several nuclear autoAgs such as U2AF 35-and 65-kDa splicing factors and 70-KDa U1 snRNP [23] , and many other splicing factors have been reported as autoAgs, such as SF3B1 and SRSF2. Therefore, we suspect that the other 3 splicing factors (SRSF3B3, SRSF7, and SRSF8) identified by DS-affinity in this study are likely true autoAgs that are yet to be confirmed.

Proteins eluted with 1.0 M NaCl possess the strongest DS-affinity and, strikingly, 10/13 (90.9%) are known autoAgs ( Table 1 ), indicating that increasing affinity to DS increases the propensity of a protein to be an autoAg, consistent with our prior findings [1-3, 5, 6, 9-11] . These include histones (H4, H2B types 1-a and 1-b, H2A type 1-a), 60S ribosomal proteins (P0, P2, L6, L7), ACTC1 (skeletal muscle actin), and C1QBP, and PABPC3 (polyadenylate-binding protein 3). Histones and ribosomal P proteins are hallmark autoAgs used in routine clinical tests of autoimmune diseases. Histone autoAbs are nearly always present in druginduced systemic lupus erythematosus, and ribosomal P autoantibodies are tested for to aid in the differential diagnosis of lupus patients with neuropsychiatric symptoms. C1QBP has been repeatedly identified as a putative autoAg in several of our prior studies [1, 2, 9, 10] and was recently confirmed as an autoAg in the neurodegenerative disorder primary open-angle glaucoma [24] . Poly(A)-binding proteins bind the poly(A) tail of messenger RNAs and control mRNA stability and translation initiation. Although PABPC3 has not yet been reported as an autoAg, its paralog PABPC1 has been found to be an autoAg [25] .

Proteins eluted with 0.6 M NaCl possess strong DS-affinity and, remarkably, 26/31 (83.9%) are known autoAgs (Table 1) . Several well-known autoAgs are identified in this strong DS-affinity fraction, including 6 histone autoAgs, SSB (lupus La autoAg), XRCC6 (lupus Ku70 autoAg), 3 snRNP autoAgs (Sm D2, Sm D3, U1 70kD). Other autoAgs identified with strong DS-affinity include ANP32B, nucleolin, nucleophosmin, SET, HNRNPCL1, HSP90AA1, 3 ribosomal proteins (L22, L5, S3a), 3 serine/arginine-rich splicing factors, 3 tropomyosin subunits, prothymosin alpha, 3 tubulin subunits, vimentin, and T-complex protein 1 alpha. A few have not yet been confirmed as autoAgs, including ANP32A, kappa actin, and ribosomal protein 3A.

The 140 candidate autoAgs identified from Jurkat T-cells are not a random collection but are highly enriched in a few groups of proteins. Among them, there are 11 proteasomal proteins, 8 ribosomal proteins, 8 histones, 8 T-complex protein (CCT/TriC) subunits, 7 heat shock proteins, 6 splicing factors, 6 14-3-3 proteins, 5 DNA replication licensing factors (or minichromosome maintenance proteins), 5 DNA or RNA helicases, and 4 hnRNPs.

Protein-protein interaction network analysis by STRING [26] reveals that the DS-affinity autoantigen-ome is highly connected (Fig. 1 ). There are 787 interactions at high confidence level (vs. 284 expected; enrichment p-value <1.0e-16). These DS-affinity proteins are enriched in several clusters and significantly associated with the cell cycle, protein folding, chromosome organization, RNA splicing, translation, and muscle contraction (Fig. 1 ). There are 36 DS-affinity proteins associated with the cell cycle, particularly the G2/M checkpoints (26 proteins) , the G2/M DNA damage checkpoint, and the G1/S and G2/M transitions.

Pathway and process enrichment analyses by Metascape [27] also reveal that proteins of the DS-affinity autoantigen-ome are significantly associated with cellular response to stress, protein folding, and protein localization to organelles ( Fig. 2A ). In addition, they are associated with kinase maturation complex 1, spliceosome, HSF1 activation (activates gene expression in response to a variety of stresses), protein processing in the endoplasmic reticulum, VEGFA-VEGFR2 signaling (major pathway that activates angiogenesis), apoptosis-induced DNA fragmentation, and 17S U2 snRNP.

To find out how many of the DS-affinity autoAgs identified from Jurkat T-cells are affected by in SARS-CoV-2 infection, we searched for them in a multi-omic COVID database compiled by Coronascape .

Among the 140 DS-affinity proteins identified in our study, 125 (89.3%) are affected by SARS-CoV-2 infection, and at least 94 (of the 125; 75.2%) are known autoAgs (Table 1 and Supplemental Table 1 ).

Among the COVID-altered DS-affinity proteins, 17 are up-regulated only, 35 are down-regulated only, and 71 are altered (up or down depending on study conditions) at protein and/or RNA levels in SARS-CoV-2 infected cells. The COVID database was assembled from different cell and patient tissue types by multiple research laboratories using different technologies, including proteomics, phosphoproteomics, ubiquitinomics, and bulk and single-cell RNA sequencing.

Six DS-affinity proteins are found in the interactomes of SARS-CoV-2 viral proteins, i.e., these host proteins interact directly or indirectly with the viral proteins [29, 40, 44] . Specifically, HSPA5 (GRP78/BiP) interacts with Nsp2 and Nsp4, HYOU1 interacts with Orf8, PRKCSH and MAPRE1 interact with Orf3, and BZW2 interacts with the viral M protein. HSPA5/BiP (binding immunoglobulin protein) has been consistently identified by DS-affinity in our previous studies, and we have also recently reported that DS-BiP association plays important roles in regulating precursor autoreactive B1 cells [8] . HYOU1 (hypoxia upregulated protein 1) was also found overexpressed at protein level in the urine of COVID-19 patients and . CC-BY 4.0 International license available under a was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made

The copyright holder for this preprint (which this version posted July 7, 2021. ; https://doi.org/10.1101/2021.07.05.451199 doi: bioRxiv preprint up-regulated at mRNA level in B cells from 4 patients out of a cohort of 7 hospitalized COVID-19 patients [33, 48] . HYOU1 belongs to the heat shock protein 70 family, accumulates in the endoplasmic reticulum under hypoxic conditions, and has been shown to be up-regulated in tumors. PRKCSH (glucosidase 2 subunit beta) is an N-linked glycan processing enzyme in the endoplasmic reticulum, and mutations of this gene have been associated with the autosomal dominant polycystic liver disease. MAPRE1 (microtubuleassociated protein RP/EB family member 1) binds the plus-end of microtubules and regulates microtubule cytoskeleton dynamics. BZW2 (basic leucine zipper and W2 domain 2) may be involved in neuronal differentiation and is associated with congenital hypomyelinating neuropathy.

Similar to the 140 DS-affinity protein autoantigen-ome, the 125 COVID-altered DS-affinity proteins are most significantly associated with RNA metabolism and protein folding (Fig. 2B ). In addition, they are associated with establishment of protein localization to organelles, kinase maturation complex 1, emerin complex 24, DNA conformation change, spliceosome, cellular response to heat stress, smooth muscle contraction, VEGFA-VESFR2 signaling pathway, prothymosin alpha C5 complex, regulation of protein dephosphorylation, and telomerase pathway (Fig. 2B ). Protein-protein interaction network analysis also confirms that the COVID-altered DS-affinity protein network is strongly associated with mRNA processing, translation, chromosome organization, protein processing in the endoplasmic reticulum, CCT/TriC chaperonin, and apoptosis ( Fig. 3 ).

Nine COVID-altered DS-affinity proteins are associated with muscle contraction, including ACTC1, CALM1, CALM3, MYL6, TPM1, TPM3, TPM4, SRSF1, and VIM. All of these proteins are known autoAgs (Table 1 ).

CALM1 has recently been identified as one of the autoAgs in multisystem inflammatory syndrome in children from SARS-CoV-2 infection [13] . Six 14-3-3 proteins are identified, all of which are autoAgs.

Presence of 14-3-3 proteins in cerebrospinal fluid, a marker of ongoing neurodegeneration, has been detected in COVID-19 patients [49] .

Thirty-eight of the 125 COVID-affected DS-affinity proteins have phosphorylation changes in SARS-CoV-2 infection (Fig. 4) . Their molecular functions include histone binding (6 proteins), RNA binding (10 proteins), helicase activity (5 proteins), ATP binding (12 proteins), DNA binding (14 proteins), and hydrolase activity (11 proteins) . These COVID-altered phosphoproteins are significantly associated with gene expression, chromosome organization, and mRNA metabolism. Chromosome-associated proteins are particularly . CC-BY 4.0 International license available under a was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made

The copyright holder for this preprint (which this version posted July 7, 2021. Ubiquitination is typically the "kiss of death" modification that marks proteins destined for degradation by the proteasome, although ubiquitination may also modulate protein interaction and activity.

Intriguingly, we identified UBA1 (ubiquitin-like modifier-activating enzyme 1), which catalyzes the first step in ubiquitin conjugation and plays a central role in ubiquitination, as a ubiquitination-altered DSaffinity autoAg, which is consistent with our previous studies [1, 2] .

Because Jurkat cells were established from human T-cell lymphoblastic leukemia, we searched for DSaffinity proteins that were altered in T cells of seven COVID-19 patients [33] . (Table 1) . NACA, ACTG1, and SRSF5, which were down-regulated at the mRNA level, are also known autoAgs. EEF1B2 (or EEF1B, elongation factor 1-beta)

. CC-BY 4.0 International license available under a was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made

The copyright holder for this preprint (which this version posted July 7, 2021. ; https://doi.org/10.1101/2021.07.05.451199 doi: bioRxiv preprint has not been identified as an autoAg, although other similar elongation factors such as EEF1A and EF2 are known autoAgs (see references in Table 1 ).

Among up-regulated proteins, LCP1 was up-regulated in CD4+ T cells of 2 patients (out of 4 patients with available data) and in CD8+ T cells of 2 patients (out of 5 patients with available data), with one of the patients having LCP1 up in both CD4+ and CD8+ T cells. Up-regulation of heat shock proteins, particularly HSPA5 and HSP90AA1, was detected in CD4+ T cells of 2 patients and CD8+ T cells of 1 patient. MCM4 upregulation was detected in CD8+ T cells of 3 out of 6 patients. Among down-regulated proteins, NACA was detected in CD4+ T cells of 1 patient and CD8+ T cells of all 3 patients whose data were available. EEF1B2 was down in CD4+ T cells of 3 patients (out of 5 with available data) and down in CD8+ T cells of 2 out of 3 patients. ACTG1 down-regulation was detected in CD4+ T cells of 2 patients and CD8+ T cells of 1 patient.

Among these T-cell-altered proteins, LCP1 and NACA are perhaps most interesting. LCP1 (plastin-2, an actin binding protein) has been found to play a significant role in T cell activation in response to costimulation through TCR/CD3 and regulates the stability of the immune synapse of naïve and effector T cells [50] . NACA (nascent polypeptide-associated complex subunit alpha) binds to newly synthesized polypeptide chains as they emerge from the ribosome, blocks their interaction with the signal recognition particle, and prevents inappropriate targeting of non-secretory polypeptides to the endoplasmic reticulum. NACA is an IgE autoAg in atopic dermatitis patients with chronic skin manifestations [51] . The significance of these T-cell proteins in COVID-19 and autoimmunity merits further study.

In order to establish a comprehensive COVID-19 autoantigen-ome, we have been profiling autoAgs from different cell and tissue types. Compared to other cells we have examined, Jurkat T-cells contain relatively fewer DS-affinity autoAgs than HFL1 lung fibroblasts, A549 lung epithelial cells, HS-Sultan B-lymphoblasts, and HEp-2 fibroblasts. Although cells share numerous autoAgs, each cell type gives rise to unique COVIDaltered autoAg candidates, which may explain the wide range of symptoms experienced by patients with autoimmune sequelae of SARS-CoV-2 infection. We believe that our effort of discovering autoAgs across different cell types provides a comprehensive and valuable autoAg database for better understanding of autoimmune diseases and post-COVID-19 health problems.

. CC-BY 4.0 International license available under a was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made

The copyright holder for this preprint (which this version posted July 7, 2021. ; https://doi.org/10.1101/2021.07.05.451199 doi: bioRxiv preprint

The human T lymphoblast Jurkat cell line was obtained from the ATCC (Manassas, VA) and cultured in complete RPMI-1640 medium. The growth medium was supplemented with 10% fetal bovine serum and a penicillin-streptomycin-glutamine mixture (Thermo Fisher). The cells were grown at 37 °C in a CO2

incubator.

Protein extraction was performed as previously described [6] . In brief, Jurkat cells were lysed with 50 mM phosphate buffer (pH 7.4) containing the Roche Complete Mini protease inhibitor cocktail and then homogenized on ice with a microprobe sonicator until the turbid mixture turned nearly clear with no visible cells left. The homogenate was centrifuged at 10,000 g at 4 °C for 20 min, and the total protein extract in the supernatant was collected. Protein concentration was measured by absorbance at 280 nm using a NanoDrop UV-Vis spectrometer (Thermo Fisher).

The DS-affinity resins were synthesized as previously described [6, 9] . In brief, 20 ml of EAH Sepharose 4B 

The total proteomes extracted from Jurkat cells were fractionated in a DS-Sepharose column [6] . About was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made

The copyright holder for this preprint (which this version posted July 7, 2021.

School. Proteins in gels were digested with sequencing-grade trypsin (Promega) at 4 °C for 45 min. Tryptic peptides were separated in a nano-scale C18 HPLC capillary column and analyzed in an LTQ linear ion-trap mass spectrometer (Thermo Fisher). Peptide sequences and protein identities were assigned by matching the measured fragmentation pattern with proteins or translated nucleotide databases using Sequest. All data were manually inspected. Proteins with ≥2 peptide matches were considered positively identified.

DS-affinity proteins were compared with currently available COVID-19 multi-omic data compiled in the Coronascape database (as of 02/22/2021) . These data have been obtained with proteomics, phosphoproteomics, interactome, ubiquitome, and RNA-seq techniques. Up-and down-regulated proteins or gene transcripts were identified by comparing cells infected vs. uninfected by SARS-CoV-2 or COVID-19 patients vs. healthy controls. Similarity searches were conducted to identify DS-affinity proteins that are up-and/or down-regulated in viral infection at any omic level.

Protein-protein interactions were analyzed by STRING [26] . Interactions include both direct physical interaction and indirect functional associations, which are derived from genomic context predictions, high-throughput lab experiments, co-expression, automated text mining, and previous knowledge in databases. Each interaction is annotated with a confidence score from 0 to 1, with 1 being the highest, indicating the likelihood of an interaction to be true. Pathways and processes enrichment were analyzed with Metascape [27] , which utilizes various ontology sources such as KEGG Pathway, GO Biological Process, Reactome Gene Sets, Canonical Pathways, CORUM, TRRUST, and DiGenBase. All genes in the genome were used as the enrichment background. Terms with a p-value <0.01, a minimum count of 3, and an enrichment factor (ratio between the observed counts and the counts expected by chance) >1.5 were collected and grouped into clusters based on their membership similarities. The most statistically significant term within a cluster was chosen to represent the cluster.

. CC-BY 4.0 International license available under a was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made

The copyright holder for this preprint (which this version posted July 7, 2021. ; https://doi.org/10.1101/2021.07.05.451199 doi: bioRxiv preprint

Every DS-affinity protein identified in this study was searched for specific autoantibodies reported in the PubMed literature. Search keywords included the MeSH keyword "autoantibodies", the protein name or its gene symbol, or alternative names and symbols. Only proteins for which specific autoantibodies are reported in PubMed-listed journal articles were considered "confirmed" or "known" autoAgs in this study.

We are grateful to Dr. Jung-hyun Rho for his technical assistance to the study. We thank Ross Tomaino and the Taplin Mass Spectrometry Facility of Harvard Medical School for expert service with protein sequencing.

This work was partially supported by Curandis, the US NIH, and a Cycle for Survival Innovation Grant (to MHR). MHR acknowledges NIH/NCI R21 CA251992 and MSKCC Cancer Center Support Grant P30 CA008748. The funding bodies were not involved in the design of the study and the collection, analysis, and interpretation of data.

Boards of Trans-Hit, Proscia, and Universal DX, but these companies have no relation to the study.

JYW conducted the study and wrote the manuscript. WZ performed some of the experiments. MWR and VBR assisted with the study and manuscript preparation. MHR consulted on the study and edited the manuscript. All authors have approved the manuscript.

. CC-BY 4.0 International license available under a was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made

The copyright holder for this preprint (which this version posted July 7, 2021. ; https://doi.org/10.1101/2021.07.05.451199 doi: bioRxiv preprint Table 1 . Abbreviations . CC-BY 4.0 International license available under a was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made

The copyright holder for this preprint (which this version posted July 7, 2021. ; https://doi.org/10.1101/2021.07.05.451199 doi: bioRxiv preprint was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made

The copyright holder for this preprint (which this version posted July 7, 2021. ; https://doi.org/10.1101/2021.07.05.451199 doi: bioRxiv preprint . CC-BY 4.0 International license available under a was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made

The copyright holder for this preprint (which this version posted July 7, 2021. ; https://doi.org/10.1101/2021.07.05.451199 doi: bioRxiv preprint CC-BY 4.0 International license available under a was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made

The copyright holder for this preprint (which this version posted July 7, 2021. ; https://doi.org/10.1101/2021.07.05.451199 doi: bioRxiv preprint

An Autoantigen Atlas from Human Lung HFL1 Cells Offers Clues to Neurological and Diverse Autoimmune Manifestations of COVID-19

An Autoantigen Profile of Human A549 Lung Cells Reveals Viral and Host Etiologic Molecular Attributes of Autoimmunity in COVID-19

An Autoantigen-ome from HS-Sultan B-Lymphoblasts Offers a Molecular Map for Investigating Autoimmune Sequelae of COVID-19

An autoantigen profile of human A549 lung cells reveals viral and host etiologic molecular attributes of autoimmunity in COVID-19

Dermatan sulfate interacts with dead cells and regulates CD5(+) B-cell fate: implications for a key role in autoimmunity

Human proteins with affinity for dermatan sulfate have the propensity to become autoantigens

Dermatan Sulfate Is a Potential Master Regulator of IgH via Interactions with Pre-BCR, GTF2I, and BiP ER Complex in Pre-B Lymphoblasts. bioRxiv

Dermatan Sulfate Is a Potential Regulator of IgH via Interactions With Pre-BCR, GTF2I, and BiP ER Complex in Pre-B Lymphoblasts

A proteomic repertoire of autoantigens identified from the classic autoantibody clinical test substrate HEp-2 cells

A comprehensive autoantigen-ome of autoimmune liver diseases identified from dermatan sulfate affinity enrichment of liver tissue proteins

A repertoire of 124 potential autoantigens for autoimmune kidney diseases identified by dermatan sulfate affinity enrichment of kidney tissue proteins

The Immunology of Multisystem Inflammatory Syndrome in Children with COVID-19

Mapping Systemic Inflammation and Antibody Responses in Multisystem Inflammatory Syndrome in Children (MIS-C)

Clinical, Serological, and Histopathological Similarities Between Severe COVID-19 and Acute Exacerbation of Connective Tissue Disease-Associated Interstitial Lung Disease (CTD-ILD)

Clinical and Autoimmune Characteristics of Severe and Critical Cases of COVID-19

High levels of anti-SSA/Ro antibodies in COVID-19 patients with severe respiratory failure: a case-based review : High levels of anti-SSA/Ro antibodies in COVID-19

SARS-CoV-2 Infection as a trigger of autoimmune response

High frequency of cerebrospinal fluid autoantibodies in COVID-19 patients with neurological symptoms

Autoantibodies stabilize neutrophil extracellular traps in COVID-19. medRxiv : the preprint server for health sciences

New-Onset IgG Autoantibodies in Hospitalized Patients with COVID-19. medRxiv : the preprint server for health sciences

Autoantibodies against type I IFNs in patients with life-threatening COVID-19

Immune-mediated neurological syndromes in SARS-CoV-2-infected patients

Novel nuclear autoantigen with splicing factor motifs identified with antibody from hepatocellular carcinoma

Autoantigens in the trabecular meshwork and glaucoma-specific alterations in the natural autoantibody repertoire

Myasthenia gravis: analysis of serum autoantibody reactivities to 1827 potential human autoantigens by protein macroarrays

STRING v11: proteinprotein association networks with increased coverage, supporting functional discovery in genome-wide experimental datasets

Metascape provides a biologist-oriented resource for the analysis of systems-level datasets

Single-cell landscape of immunological responses in patients with COVID-19

Comparative Multiplexed Interactomics of SARS-CoV-2 and Homologous Coronavirus Nonstructural Proteins Identifies Unique and Shared Host-Cell Dependencies

Growth Factor Receptor Signaling Inhibition Prevents SARS-CoV-2 Replication

Comparative Transcriptome Analysis Reveals the Intensive Early Stage Responses of Host Cells to SARS-CoV-2 Infection

Proteomics of SARS-CoV-2-infected host cells reveals therapy targets

A single-cell atlas of the peripheral immune response in patients with severe COVID-19

In vivo antiviral host transcriptional response to SARS-CoV-2 by viral load, sex, and age

Discovery of SARS-CoV-2 antiviral drugs through large-scale compound repurposing

The Global Phosphorylation Landscape of SARS-CoV-2 Infection

Imbalanced Host Response to SARS-CoV-2 Drives Development of COVID-19

Proteomic and Metabolomic Characterization of COVID-19

SARS-CoV-2 productively infects human gut enterocytes

A SARS-CoV-2 protein interaction map reveals targets for drug repurposing

Transcriptomic characteristics of bronchoalveolar lavage fluid and peripheral blood mononuclear cells in COVID-19 patients. Emerging microbes & infections

Type I and Type III Interferons Restrict SARS-CoV-2 Infection of Human Airway Epithelial Cultures

Dysregulation in Akt/mTOR/HIF-1 signaling identified by proteo-transcriptomics of SARS-CoV-2 infected cells. Emerging microbes & infections

Multi-level proteomics reveals host-perturbation strategies of SARS-CoV-2 and SARS-CoV

Bulk and single-cell gene expression profiling of SARS-CoV-2 infected human cell lines identifies molecular targets for therapeutic intervention

Single-cell landscape of bronchoalveolar immune cells in patients with COVID-19

Global BioID-based SARS-CoV-2 proteins proximal interactome unveils novel ties between viral polypeptides and host factors involved in multiple COVID19-associated mechanisms

Urine proteome of COVID-19 patients

Anti-SARS-CoV-2 antibodies in the CSF, blood-brain barrier dysfunction, and neurological outcome: Studies in 8 stuporous and comatose patients

L-plastin regulates the stability of the immune synapse of naive and effector T-cells. Advances in biological regulation

Characterization of a novel isoform of alpha-nascent polypeptide-associated complex as

An autoantibody profile detects Brugada syndrome and identifies abnormally expressed myocardial proteins

Autoantibodies in three populations of Burkitt's lymphoma patients

Alpha actinin is specifically recognized by Multiple Sclerosis autoantibodies isolated using an N-glucosylated peptide epitope

Autoantibodies against BAFF, APRIL or IL21 -an alternative pathogenesis for antibody-deficiencies?

A case of neonatal lupus erythematosus presenting delayed dilated cardiomyopathy with circulating autoantibody to annexin A6

Auto-antibodies to β-F1-ATPase and vimentin in malignant mesothelioma

Autoantigens in the trabecular meshwork and glaucoma-specific alterations in the natural autoantibody repertoire

Mapping Systemic Inflammation and Antibody Responses in Multisystem Inflammatory Syndrome in Children (MIS-C)

Antibody that recognizes conformations of calmodulin in the serum from patient with chronic active hepatitis

Systemic lupus erythematosus is associated with increased auto-antibody titers against calreticulin and grp94, but calreticulin is not the Ro/SS-A antigen

Identification of novel citrullinated autoantigens of synovium in rheumatoid arthritis using a proteomic approach

Autoantibodies against chaperonin CCT in human sera with rheumatic autoimmune diseases: comparison with antibodies against other Hsp60 family proteins

Serum antibody response to group II chaperonin from Methanobrevibacter oralis and human chaperonin CCT

Human proteins with affinity for dermatan sulfate have the propensity to become autoantigens

Evaluation of a panel of tumor-associated antigens in breast cancer. Cancer biomarkers : section A of Disease markers

Identification of autoantibody against fatty acid synthase in hepatocellular carcinoma mouse model and its application to diagnosis of HCC

Relationship between sex and antibodies to high mobility group proteins 1 and 2 in juvenile idiopathic arthritis

Mapping of B-cell epitopes recognized by antibodies to histones in subsets of juvenile chronic arthritis

Autoantibodies against different histone H1 subtypes in systemic lupus erythematosus sera

Variable region genes of human monoclonal autoantibodies to histones H2A and H2B from a systemic lupus erythematosus patient

Autoantibodies against Modified Histone Peptides in SLE Patients Are Associated with Disease Activity and Lupus Nephritis

Antibodies to hnRNP core protein A1 in connective tissue diseases

Heterogenous nuclear RNP C1 and C2 core proteins are targets for an autoantibody found in the serum of a patient with systemic sclerosis and psoriatic arthritis

A novel cytoplasmic protein with RNA-binding motifs is an autoantigen in human hepatocellular carcinoma

Cell nonhomologous end joining capacity controls SAF-A phosphorylation by DNA-PK in response to DNA double-strand breaks inducers

Identification of citrullinated hsp90 isoforms as novel autoantigens in rheumatoid arthritis-associated interstitial lung disease

Autoantibodies to heat shock protein 90 in the human natural antibody repertoire

Type 1 diabetes alters anti-hsp90 autoantibody isotype

Anti-heat-shock protein antibodies in rheumatic and autoimmune diseases

The stress protein BiP is overexpressed and is a major B and T cell target in rheumatoid arthritis

Antibodies against different epitopes of heat-shock protein 60 in children with type 1 diabetes mellitus

The increment of anti-ORP150 autoantibody in initial stages of atheroma in high-fat diet fed mice. The Journal of veterinary medical science

Importin beta: a novel autoantigen in human autoimmunity identified by screening random peptide libraries on phage

Identification of L-plastin autoantibody in plasma of patients with non-Hodgkin's lymphoma using a proteomics-based analysis

Strong association of autoantibodies to human nuclear lamin B1 with lupus anticoagulant antibodies in systemic lupus erythematosus

Identification of candidate endothelial cell autoantigens in systemic lupus erythematosus using a molecular cloning strategy: a role for ribosomal P protein P0 as an endothelial cell autoantigen

Autoantibodies to myosin light chains in the blood as early marker of myocardial injury after aortocoronary bypass surgery

Characterization of a novel isoform of alpha-nascent polypeptide-associated complex as IgE-defined autoantigen

Analysis of the autoimmune epitopes on human testicular NASP using recombinant and synthetic peptides

Antibodies against nucleolin in recipients of organ transplants

Unique conformation of cancer autoantigen B23 in hepatoma: a mechanism for specificity in the autoimmune response

Occurrence of autoantibody to protein disulfide isomerase in patients with hepatic disorder

Glyceraldehyde 3-phosphate dehydrogenase is a novel autoantigen leading autoimmune responses to proliferating cell nuclear antigen multiprotein complexes in lupus patients

Molecular mimicry in halothane hepatitis: biochemical and structural characterization of lipoylated autoantigens

Immunoproteomics of HER2-positive and HER2-negative breast cancer patients with positive lymph nodes

The proteasome is a major autoantigen in multiple sclerosis

Autoantibodies in primary Sjögren's syndrome are directed against proteasomal subunits of the alpha and beta type

Characterization of spermatozoa surface antigens by antisperm antibodies and its influence on acrosomal exocytosis

Novel autoantibodies against the proteasome subunit PSMA7 in amyotrophic lateral sclerosis

Identification of PSME3 as a novel serum tumor marker for colorectal cancer by combining two-dimensional polyacrylamide gel electrophoresis with a strictly mass spectrometry-based approach for data analysis

Circulating antibodies to prothymosin alpha in systemic lupus erythematosus

Autoantibodies against the replication protein A complex in systemic lupus erythematosus and other autoimmune diseases

The Immunome of Colon Cancer: Functional In Silico Analysis of Antigenic Proteins Deduced from IgG Microarray Profiling

Anti-5S

RNA/protein (RNP) antibody levels correlate with disease activity in a patient with systemic lupus erythematosus (SLE) nephritis

Anti-ribosomal P protein antibodies

Properties of the ribosomal P2 protein autoantigen are similar to those of foreign protein antigens

SET-related cell division autoantigen-1 (CDA1) arrests cell growth

Autoantibodies specific for apoptotic U1-70K are superior serological markers for mixed connective tissue disease

Anti-sm autoantibodies in systemic lupus target highly basic surface structures of complexed spliceosomal autoantigens

The C-terminal RG dipeptide repeats of the spliceosomal Sm proteins D1 and D3 contain symmetrical dimethylarginines, which form a major B-cell epitope for anti-Sm autoantibodies

Novel nuclear autoantigen with splicing factor motifs identified with antibody from hepatocellular carcinoma

Identification of autoantigens specific for systemic lupus erythematosus with central nervous system involvement

Small nucleolar RNP scleroderma autoantigens associate with phosphorylated serine/arginine splicing factors during apoptosis

Anti-52 kDa Ro, anti-60 kDa Ro, and anti-La antibody profiles in neonatal lupus

Identification of novel non-myelin biomarkers in multiple sclerosis using an improved phage-display approach

Tropomyosin isoforms in intestinal mucosa: production of autoantibodies to tropomyosin isoforms in ulcerative colitis

Alpha tropomyosin as a self-antigen in patients with Behcet's disease

Anti-endothelial cell antibodies in patients with cerebral small vessel disease

Anti-tubulin-alpha-1C autoantibody in systemic lupus erythematosus: a novel indicator of disease activity and vasculitis manifestations

Identification of target antigens of naturally occurring autoantibodies in cerebrospinal fluid

Clinical and human leucocyte antigen class II haplotype associations of autoantibodies to small ubiquitin-like modifier enzyme, a dermatomyositis-specific autoantigen target, in UK Caucasian adult-onset myositis

Anti-p97/VCP antibodies: an autoantibody marker for a subset of primary biliary cirrhosis patients with milder disease?

Mutation and citrullination modifies vimentin to a novel autoantigen for rheumatoid arthritis

Mining the pre-diagnostic antibody repertoire of TgMMTV-neu mice to identify autoantibodies useful for the early detection of human breast cancer

Mapping of epitopes on the 86 kDa subunit of the Ku autoantigen

Single-specificity anti-Ku antibodies in an international cohort of 2140 systemic sclerosis subjects: clinical associations

Characteristics of autoantibodies targeting 14-3-3 proteins and their association with clinical features in newly diagnosed giant cell arteritis

A prospective cohort study of 14-3-3eta in ACPA and/or RF-positive patients with arthralgia

Occurrence of autoantibodies to annexin I, 14-3-3 theta and LAMR1 in prediagnostic lung cancer sera

Thoracic Aortic Aneurysms: Identification of a Novel Autoantigen in Large Vessel Vasculitis. Arthritis & rheumatology